Eagle Bay Advisors LLC Charles River Laboratories International, Inc. Transaction History

Eagle Bay Advisors LLC

$170 Million
Q3 2024

A detailed history of Eagle Bay Advisors LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 533 shares of CRL stock, worth $107,292. This represents 0.06% of its overall portfolio holdings.

Number of Shares

533

Previous 608 12.34%

Holding current value

$107,292

Previous $125,000 16.8%

% of portfolio

0.06%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$187.96 - $245.29 $14,097 - $18,396	-75 Reduced 12.34%	533 $104,000
Q2 2024 Jul 26, 2024	SELL	$206.39 - $268.73 $8,049 - $10,480	-39 Reduced 6.03%	608 $125,000
Q1 2024 May 08, 2024	SELL	$203.52 - $273.43 $32,156 - $43,201	-158 Reduced 19.63%	647 $175,000
Q4 2023 Feb 08, 2024	SELL	$164.52 - $238.84 $6,580 - $9,553	-40 Reduced 4.73%	805 $190,000
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $34,804 - $38,952	179 Added 26.88%	845 $165,000
Q2 2023 Aug 10, 2023	SELL	$183.71 - $210.25 $20,942 - $23,968	-114 Reduced 14.62%	666 $140,000
Q1 2023 Apr 24, 2023	SELL	$191.89 - $259.92 $10,553 - $14,295	-55 Reduced 6.59%	780 $157,000
Q4 2022 Jan 26, 2023	BUY	$197.11 - $250.07 $108,410 - $137,538	550 Added 192.98%	835 $0
Q3 2022 Nov 22, 2022	SELL	$182.44 - $250.54 $63,489 - $87,187	-348 Reduced 54.98%	285 $57,000
Q2 2022 Aug 19, 2022	BUY	$204.13 - $302.4 $97,574 - $144,547	478 Added 308.39%	633 $135 Million
Q1 2022 May 11, 2022	SELL	$255.51 - $362.11 $40,370 - $57,213	-158 Reduced 50.48%	155 $44,000
Q4 2021 Jan 21, 2022	BUY	$351.38 - $448.68 $16,866 - $21,536	48 Added 18.11%	313 $118,000
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $30,556 - $37,580	-82 Reduced 23.63%	265 $108,000
Q2 2021 Jul 30, 2021	BUY	$294.17 - $371.65 $102,076 - $128,962	347 New	347 $130,000

Others Institutions Holding CRL

# of Institutions

698

Shares Held

52.3M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Account

Eagle Bay Advisors LLC Charles River Laboratories International, Inc. Transaction History